Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome)

American Journal of Ophthalmology

Volumn 140, Issue 2, 2005, Pages 267.e1-267.e9

  Egan, Robert A ^a,b,f   Weleber, Richard G ^a   Hogarth, Penelope ^b   Gregory, Allison ^a   Coryell, Jason ^a   Westaway, Shawn K ^a   Gitschier, Jane ^c   Das, Soma ^d   Hayflick, Susan J ^a,b,e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f CASEY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOTHENATE KINASE;

ADIE SYNDROME; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BINOCULAR CONVERGENCE; BLEPHAROSPASM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA REFLEX; CORRELATION ANALYSIS; ELECTRORETINOGRAPHY; FEMALE; GENE MUTATION; GENETICS; GENOTYPE; HALLERVORDEN SPATZ DISEASE; HUMAN; IRIS; MALE; NERVE DEGENERATION; NEUROIMAGING; NEUROOPHTHALMOLOGY; OPTIC NERVE ATROPHY; OPTOKINETIC STIMULATION; PHENOTYPE; PRIORITY JOURNAL; RETINA CONE; RETINA ROD; RETINOPATHY; SACCADIC EYE MOVEMENT;

EID: 23744440327     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.03.024     Document Type: Article

References (25)

1. K.F. Swaiman Hallervorden-Spatz syndrome and brain iron metabolism Arch Neurol 48 1991 1285 1293
2. E.C. Dooling, W.C. Schoene, E.P. Richardson Jr Hallervorden-Spatz syndrome Arch Neurol 30 1974 70 83
3. M. Thomas, S.J. Hayflick, J. Jankovic Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration Mov Disord 19 2004 36 42
4. B. Zhou, S.K. Westaway, B. Levinson, M.A. Johnson, J. Gitschier, S.J. Hayflick A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome Nat Genet 28 2001 345 349
5. M. Neumann, S. Adler, O. Schluter, E. Kremmer, R. Benecke, H.A. Kretzschmar Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies Acta Neuropathol (Berl) 100 2000 568 574
6. R.N. Sener Pantothenate kinase-associated neurodegeneration MR imaging, proton MR spectroscopy, and diffusion MR imaging findings AJNR Am J Neuroradiol 24 2003 1690 1693
7. N. Sodeyama, M. Arai, N. Sanjoh, S. Orimo, M. Tamaki [A case of Hallervorden-Spatz syndrome with marked atrophy of the brainstem and cerebellum] Rinsho Shinkeigaku 33 1993 525 529
8. R.G. Weleber The effect of age on human cone and rod ganzfeld electroretinograms Invest Ophthalmol Vis Sci 20 1981 392 399
9. R.G. Weleber The dystrophic retina in multisystem disorders the electroretinogram in neuronal ceroid lipofuscinoses Eye 12 Pt 3b 1998 580 590
10. R.G. Weleber, A. Eisner Retinal function and physiological studies Newsome DA Retinal dystrophies and degenerations 1988 Raven Press New York, NY 21 69
11. M.F. Marmor, E. Zrenner Standard for clinical electroretinography (1994 update) Doc Ophthalmol 89 1995 199 210
12. S.J. Hayflick, S.K. Westaway, B. Levinson Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome N Engl J Med 348 2003 33 40
13. P.A. Battistella, E. Midena, A. Suppiej, C. Carollo Optic atrophy as the first symptom in Hallervorden-Spatz syndrome Childs Nerv Syst 14 1998 135 138
14. M. Feliciani, P. Curatolo Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease Neuroradiology 36 1994 247 248
15. S.J. Hickman, N.S. Ward, R.A. Surtees, J.M. Stevens, S.F. Farmer How broad is the phenotype of Hallervorden-Spatz disease? Acta Neurol Scand 103 2001 201 203
16. A.H. Koeppen, A.C. Dickson Iron in the Hallervorden-Spatz syndrome Pediatr Neurol 25 2001 148 155
17. L. Porter-Grenn, R. Silbergleit, B.A. Mehta Hallervorden-Spatz disease with bilateral involvement of globus pallidus and substantia nigra MR demonstration J Comput Assist Tomogr 17 1993 961 963
18. R.C. Tripathi, B.J. Tripathi, S.C. Bauserman, J.K. Park Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome Acta Neuropathol (Berl) 83 1992 113 119
19. E.L. Berson, B. Rosner, E. Simonoff Risk factors for genetic typing and detection in retinitis pigmentosa Am J Ophthalmol 89 1980 763 775
20. J. Heckenlively The frequency of posterior subcapsular cataract in the hereditary retinal degenerations Am J Ophthalmol 93 1982 733 738
21. R. Egan, S. Lessell Posterior subcapsular cataract in Degos disease Am J Ophthalmol 129 2000 806 807
22. M.W. Luckenbach, W.R. Green, N.R. Miller, H.W. Moser, A.W. Clark, G. Tennekoon Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy Am J Ophthalmol 95 1983 369 382
23. J.R. Heckenlively Retinitis pigmentosa 1988 JP Lippincott Co Philadelphia 68 89
24. R.G. Weleber, K. Gregory-Evans Retinitis pigmentosa and allied disorders S.J. Ryan Retina 3rd. ed. 2001 Mosby-Year Book, Inc St. Louis, MO 362 460
25. J.R. Heckenlively, D.A. Martin, T.O. Rosales Telangiectasia and optic atrophy in cone-rod degenerations Arch Ophthalmol 99 1981 1983 1991